£10.4M
The financing was co-ordinated by WG Partners to support analytical platform expansion and new therapeutics programmes.

PrecisionLife develops AI-led drug discovery platforms for chronic disease.
PrecisionLife is a techbio company that uses artificial intelligence to drive drug discovery and clinical development for chronic diseases. The firm operates globally with a focus on patient data analytics and precision medicine.
Steve Gardner
CEO
Sue Charles
The financing was co-ordinated by WG Partners to support analytical platform expansion and new therapeutics programmes.